Home/SEC 13D/G/ARTLSEC 13D/GARTL - Artelo Biosciences, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified$ARTL$0.85βΌ -78.04% YTDHealthcareAug 14, 2026 Β· ThinkSabio BlogSEC Filing Update: #ARTL Artelo Biosciences, Inc. : $0.85 Sector: Healthcare | YTD: π½ -78.04% The SEC disclosed Today (14-AUG-2026) that ARMISTICE CAPITAL, LLC has DECREASED #ARTL Shares by -100.00% π΄ * Previous Holdings: 235.82K Shares * Current Holdings: 0.00 Shares * Decrease -235.82K * Decreased (%)-100.00% * Ownership: 0.0% https://www.thinksabio.com/reports/isr/ARTL Institutional ownership in #ARTL has been steadily rising over the past 7 quarters in Shares: Q3 2024: 1.25K Q4 2024: 1.92K Q1 2025: 4.81K Q2 2025: 5.53K Q3 2025: 11.01K Q4 2025: 32.83K Q1 2026: 46.49K π Institutional activity in the last 30 days for #ARTL: β’ INTRACOASTAL CAPITAL, LLC β Increased holdings by 92,213 shares (13-AUG-2026) Share this postπCopy LinkMore filings for $ARTLARTL - Artelo Biosciences, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026π¬ Comments Loading commentsβ¦Leave a commentPost Commentβ All PostsMore SEC 13D/G